Literature DB >> 27815633

Multimodal evaluation demonstrates in vivo 18F-AV-1451 uptake in autopsy-confirmed corticobasal degeneration.

Corey T McMillan1, David J Irwin2, Ilya Nasrallah3, Jeffrey S Phillips2, Meredith Spindler2, Katya Rascovsky2, Kylie Ternes2, Charles Jester2, David A Wolk2, Linda K Kwong4, Virginia M-Y Lee4, Edward B Lee4, John Q Trojanowski5, Murray Grossman2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27815633      PMCID： PMC5154298          DOI： 10.1007/s00401-016-1640-3

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN： 0001-6322            Impact factor:   17.088


× No keyword cloud information.
  9 in total

Review 1.  Neuropathology of frontotemporal lobar degeneration-tau (FTLD-tau).

Authors:  Dennis W Dickson; Naomi Kouri; Melissa E Murray; Keith A Josephs
Journal:  J Mol Neurosci       Date:  2011-07-01       Impact factor: 3.444

2.  In Vivo Tau, Amyloid, and Gray Matter Profiles in the Aging Brain.

Authors:  Jorge Sepulcre; Aaron P Schultz; Mert Sabuncu; Teresa Gomez-Isla; Jasmeer Chhatwal; Alex Becker; Reisa Sperling; Keith A Johnson
Journal:  J Neurosci       Date:  2016-07-13       Impact factor: 6.167

3.  [18F]AV-1451 tau-PET uptake does correlate with quantitatively measured 4R-tau burden in autopsy-confirmed corticobasal degeneration.

Authors:  Keith A Josephs; Jennifer L Whitwell; Pawel Tacik; Joseph R Duffy; Matthew L Senjem; Nirubol Tosakulwong; Clifford R Jack; Val Lowe; Dennis W Dickson; Melissa E Murray
Journal:  Acta Neuropathol       Date:  2016-09-19       Impact factor: 17.088

4.  Florbetapir (F18-AV-45) PET to assess amyloid burden in Alzheimer's disease dementia, mild cognitive impairment, and normal aging.

Authors:  Keith A Johnson; Reisa A Sperling; Christopher M Gidicsin; Jeremy S Carmasin; Jacqueline E Maye; Ralph E Coleman; Eric M Reiman; Marwan N Sabbagh; Carl H Sadowsky; Adam S Fleisher; P Murali Doraiswamy; Alan P Carpenter; Christopher M Clark; Abhinay D Joshi; Ming Lu; Michel Grundman; Mark A Mintun; Michel J Pontecorvo; Daniel M Skovronsky
Journal:  Alzheimers Dement       Date:  2013-01-30       Impact factor: 21.566

5.  Validating novel tau positron emission tomography tracer [F-18]-AV-1451 (T807) on postmortem brain tissue.

Authors:  Marta Marquié; Marc D Normandin; Charles R Vanderburg; Isabel M Costantino; Elizabeth A Bien; Lisa G Rycyna; William E Klunk; Chester A Mathis; Milos D Ikonomovic; Manik L Debnath; Neil Vasdev; Bradford C Dickerson; Stephen N Gomperts; John H Growdon; Keith A Johnson; Matthew P Frosch; Bradley T Hyman; Teresa Gómez-Isla
Journal:  Ann Neurol       Date:  2015-09-25       Impact factor: 10.422

6.  Characterization of tau positron emission tomography tracer [18F]AV-1451 binding to postmortem tissue in Alzheimer's disease, primary tauopathies, and other dementias.

Authors:  Kerstin Sander; Tammaryn Lashley; Priya Gami; Thibault Gendron; Mark F Lythgoe; Jonathan D Rohrer; Jonathan M Schott; Tamas Revesz; Nick C Fox; Erik Årstad
Journal:  Alzheimers Dement       Date:  2016-02-15       Impact factor: 21.566

7.  18F-AV-1451 tau PET imaging correlates strongly with tau neuropathology in MAPT mutation carriers.

Authors:  Ruben Smith; Andreas Puschmann; Michael Schöll; Tomas Ohlsson; John van Swieten; Michael Honer; Elisabet Englund; Oskar Hansson
Journal:  Brain       Date:  2016-06-29       Impact factor: 13.501

8.  Multimodal imaging evidence of pathology-mediated disease distribution in corticobasal syndrome.

Authors:  Corey T McMillan; Clara Boyd; Rachel G Gross; Jessica Weinstein; Kim Firn; Jon B Toledo; Katya Rascovsky; Leslie Shaw; David A Wolk; David J Irwin; Edward B Lee; John Q Trojanowski; Murray Grossman
Journal:  Neurology       Date:  2016-08-19       Impact factor: 9.910

9.  An autoradiographic evaluation of AV-1451 Tau PET in dementia.

Authors:  Val J Lowe; Geoffry Curran; Ping Fang; Amanda M Liesinger; Keith A Josephs; Joseph E Parisi; Kejal Kantarci; Bradley F Boeve; Mukesh K Pandey; Tyler Bruinsma; David S Knopman; David T Jones; Leonard Petrucelli; Casey N Cook; Neill R Graff-Radford; Dennis W Dickson; Ronald C Petersen; Clifford R Jack; Melissa E Murray
Journal:  Acta Neuropathol Commun       Date:  2016-06-13       Impact factor: 7.801
  9 in total
  44 in total

1.  18F-AV-1451 positron emission tomography in neuropathological substrates of corticobasal syndrome.

Authors:  Anna E Goodheart; Joseph J Locascio; Wesley R Samore; Jessica A Collins; Michael Brickhouse; Aaron Schultz; Alexandra Touroutoglou; Keith A Johnson; Matthew P Frosch; John H Growdon; Bradford C Dickerson; Stephen N Gomperts
Journal:  Brain       Date:  2021-02-12       Impact factor: 13.501

2.  [18F] AV-1451 uptake in corticobasal syndrome: the influence of beta-amyloid and clinical presentation.

Authors:  F Ali; J L Whitwell; P R Martin; M L Senjem; D S Knopman; C R Jack; V J Lowe; R C Petersen; B F Boeve; K A Josephs
Journal:  J Neurol       Date:  2018-03-01       Impact factor: 4.849

3.  Asymmetry of post-mortem neuropathology in behavioural-variant frontotemporal dementia.

Authors:  David J Irwin; Corey T McMillan; Sharon X Xie; Katya Rascovsky; Vivianna M Van Deerlin; H Branch Coslett; Roy Hamilton; Geoffrey K Aguirre; Edward B Lee; Virginia M Y Lee; John Q Trojanowski; Murray Grossman
Journal:  Brain       Date:  2018-01-01       Impact factor: 13.501

Review 4.  Emerging Diagnostic and Therapeutic Strategies for Tauopathies.

Authors:  David Coughlin; David J Irwin
Journal:  Curr Neurol Neurosci Rep       Date:  2017-09       Impact factor: 5.081

5.  Progressive Supranuclear Palsy and Corticobasal Degeneration.

Authors:  David G Coughlin; Dennis W Dickson; Keith A Josephs; Irene Litvan
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

6.  Corticobasal degeneration: key emerging issues.

Authors:  F Ali; K A Josephs
Journal:  J Neurol       Date:  2017-10-23       Impact factor: 4.849

7.  Tau-PET imaging with [18F]AV-1451 in primary progressive apraxia of speech.

Authors:  Rene L Utianski; Jennifer L Whitwell; Christopher G Schwarz; Matthew L Senjem; Nirubol Tosakulwong; Joseph R Duffy; Heather M Clark; Mary M Machulda; Ronald C Petersen; Clifford R Jack; Val J Lowe; Keith A Josephs
Journal:  Cortex       Date:  2018-01-02       Impact factor: 4.027

8.  Pathological correlations of [F-18]-AV-1451 imaging in non-alzheimer tauopathies.

Authors:  Marta Marquié; Marc D Normandin; Avery C Meltzer; Michael Siao Tick Chong; Nicolas V Andrea; Alejandro Antón-Fernández; William E Klunk; Chester A Mathis; Milos D Ikonomovic; Manik Debnath; Elizabeth A Bien; Charles R Vanderburg; Isabel Costantino; Sara Makaretz; Sarah L DeVos; Derek H Oakley; Stephen N Gomperts; John H Growdon; Kimiko Domoto-Reilly; Diane Lucente; Bradford C Dickerson; Matthew P Frosch; Bradley T Hyman; Keith A Johnson; Teresa Gómez-Isla
Journal:  Ann Neurol       Date:  2017-01       Impact factor: 10.422

9.  A 2-Step Cerebrospinal Algorithm for the Selection of Frontotemporal Lobar Degeneration Subtypes.

Authors:  Alberto Lleó; David J Irwin; Ignacio Illán-Gala; Corey T McMillan; David A Wolk; Edward B Lee; Vivianna M Van Deerlin; Leslie M Shaw; John Q Trojanowski; Murray Grossman
Journal:  JAMA Neurol       Date:  2018-06-01       Impact factor: 18.302

10.  Sensitivity-Specificity of Tau and Amyloid β Positron Emission Tomography in Frontotemporal Lobar Degeneration.

Authors:  Alma Ghirelli; Nirubol Tosakulwong; Stephen D Weigand; Heather M Clark; Farwa Ali; Hugo Botha; Joseph R Duffy; Rene L Utianski; Marina Buciuc; Melissa E Murray; Sydney A Labuzan; Anthony J Spychalla; Nha Trang Thu Pham; Christopher G Schwarz; Matthew L Senjem; Mary M Machulda; Matthew Baker; Rosa Rademakers; Massimo Filippi; Clifford R Jack; Val J Lowe; Joseph E Parisi; Dennis W Dickson; Keith A Josephs; Jennifer L Whitwell
Journal:  Ann Neurol       Date:  2020-09-12       Impact factor: 10.422
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.